Project Briefs
Pharmaceutical Industry: Compliance Remediation
Capability
Operational Improvement
Regulatory, Compliance & Quality
Client
A major generic pharmaceutical company
Problem
The client was under intense regulatory scrutiny and had received a number of 483s over a 2 year span. The FDA identified the company’s Standard Operating Procedures (SOPs) as needing improvement:
- SOPs were not up-to-date and contained procedural inaccuracies
- Multiple SOPs existed for the same activities, and duplicate SOPs sometimes differed in instructions
- SOPs were not being consistently utilized by staff
- Departments were not taking ownership of SOPs
Approach
A team of Tunnell Subject Matter Experts reviewed and revised the company’s entire portfolio of SOPs. This team, consisting of experts in Manufacturing, Regulatory Affairs, Quality Assurance, Quality Control, R&D, Engineering, and Analytical Research, worked with the client’s process owners and staff to:
- Conduct a Gap Analysis vs. current procedures by observing execution of the SOP activities
- Interview process stakeholders to identify potential improvements or undocumented practices
- Incorporate industry best practices into processes
- Revise SOPs and prepare required change management documentation.
Results
Once fully implemented the improvement program will result in:
- Gaps in instructions eliminated--increased detail and descriptions added to facilitate consistent execution of the instructions
- Reduced Deviations and Investigations from improper execution of tasks
- Better training and preparation of new and existing employees
- SOPs created in collaboration with Supervisors and Operators to improve compliance and reinforce a sense of document ownership
- SOPs converted to “Step Action” format for ease of use
- Process Maps created and added to facilitate SOP use and understanding
- Pictures added to identify key components and actions
- Over 8500 SOPs reviewed and revised; approximately 125 SOPs eliminated or streamlined.

